Lilly reports strong fourth quarter on rising sales of Trulicity, Taltz
The Indianapolis-based drugmaker exceeded analyst expectations for both profit and revenue during the most recent quarter.
The Indianapolis-based drugmaker exceeded analyst expectations for both profit and revenue during the most recent quarter.
The Indianapolis-based health care insurer’s earnings more than doubled, to $934 million, in the fourth quarter, compared with $424 million in the same quarter of 2018.
The Indiana House approved legislation that would attempt to end surprise billing, and the Indiana Senate approved a bill that could establish a statewide all-payer claims database.
Businesses around the world that have grown increasingly reliant on big-spending tourists from China are taking a heavy hit, with tens of millions of Chinese residents restricted from leaving their country as the coronavirus spreads.
Chinese health authorities have confirmed 2,750 cases of the coronavirus along with 81 related deaths as authorities extended a week-long public holiday by an extra three days as a precaution against having the virus spread still further.
Indiana University Health’s new Schwarz Cancer Center is the latest addition to a crowded landscape of cancer centers and hospital oncology programs popping up around central Indiana.
The House and Senate will need to reach agreement on a single version in the coming weeks of the legislative session.
The measures are largely focused on ending surprise billing for patients, creating an all-payer claims database and requiring health care providers to give patients costs estimates in advance.
OurHealth, a fast-growing, 11-year-old Indianapolis-based company that provides medical clinics for employers in Indiana and five other states, is merging with a Vermont company, creating a combined operation with 200 clinics in 40 states.
Eli Lilly and Co. said it considered sites in Indianapolis and Pennsylvania but chose North Carolina for quality of life, cost of operations and geographical diversity.
In 2018, 7.3 out of every 1,000 babies born in Indiana died in their first year of life, one of the highest rates in the nation. Last year, the rate dipped to 6.8 per 1,000.
The doctor, an obstetrician and gynecologist, claimed she had been wrongly accused of having alcohol on her breath while on duty.
A high-stakes suit this month by the federal government against Community Health Network is raising questions about when they are proper and when they cross the line.
Under fire over insulin prices, the Indianapolis-based drugmaker said Tuesday morning it is introducing lower-priced versions of its Humalog KwikPen and Humalog Junior KwikPen.
Upscale, fast service, with lots of consumer touches: It’s a growing model for retail health care in Indiana and around the nation.
Analysts have said that Dermira’s lead pipeline product, lebrikizumab, has the potential to be the best in class among a wave of similar antibodies to treat eczema.
A city hearing examiner recused herself from ruling on a variance for a proposed 40,000-square-foot health and family center at Broad Ripple Park. The recusal automatically advances the proposal to the city’s Metropolitan Development Commission.
The eight-year-old biotech startup is developing treatments for gastrointestinal disorders, and last year hired a new CEO. It’s unclear how many employees remain in Indiana, or how much longer the company will keep a local office.
The Indiana House Public Health Committee on Wednesday discussed legislation that would create an all-payer claims database and require health care providers to give patients a “good faith” cost estimate of non-emergency procedures in advance, if requested by the patient.
The judge vacated a $3 million jury award against Cook Medical, saying a Georgia woman who sued the Bloomington-based device maker “did not have overwhelming evidence” to show the company’s implanted blood-clot filter was defective or caused her injuries.